SANARA MEDTECH INC. Research and Development Expense
SANARA MEDTECH INC. (SMTI) reported Research and Development Expense of $1.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-11
- SANARA MEDTECH INC. research and development expense for the quarter ending 2026-06-30 was $1.15M, a 9.22% increase year-over-year.
- SANARA MEDTECH INC. research and development expense for the quarter ending 2026-03-31 was $759.59K, a 20.07% decline year-over-year.
- SANARA MEDTECH INC. research and development expense for the quarter ending 2025-12-31 was $2.04M, a 130.44% increase year-over-year.
- SANARA MEDTECH INC. research and development expense for the quarter ending 2025-09-30 was $1.03M, a 31.35% increase year-over-year.
- SANARA MEDTECH INC. research and development expense for fiscal 2025 was $5.07M, a 79.32% increase from fiscal 2024.
- SANARA MEDTECH INC. research and development expense for fiscal 2024 was $2.83M, a 31.55% decline from fiscal 2023.
- SANARA MEDTECH INC. research and development expense for fiscal 2023 was $4.13M, a 22.73% increase from fiscal 2022.
- SANARA MEDTECH INC. research and development expense for fiscal 2022 was $3.37M, a 502.65% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.15M 10-Q · filed 2026-08-11 | $1.91M 10-Q · filed 2026-08-11 | $3.95M derived: sum of 3 quarters · filed 2026-08-11 | $4.98M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $759.59K 10-Q · filed 2026-05-12 | $2.80M derived: sum of 2 quarters · filed 2026-05-12 | $3.82M derived: sum of 3 quarters · filed 2026-05-12 | $4.88M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $3.07M derived: sum of 2 quarters · filed 2026-03-24 | $4.12M derived: sum of 3 quarters · filed 2026-08-11 | $5.07M 10-K · filed 2026-03-24 | ||||
| 2025-09-30 | $1.03M 10-Q · filed 2025-11-12 | $2.09M derived: sum of 2 quarters · filed 2026-08-11 | $3.04M 10-Q · filed 2025-11-12 | $3.92M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $1.06M 10-Q · filed 2026-08-11 | $1.26M 10-Q · filed 2025-08-13 | $2.01M 10-Q · filed 2026-08-11 | $2.37M 10-Q · filed 2025-08-13 | $2.89M derived: sum of 3 quarters · filed 2026-08-11 | $3.67M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-03-31 | $950.36K 10-Q · filed 2026-05-12 | $1.11M 10-Q · filed 2025-05-14 | $1.83M derived: sum of 2 quarters · filed 2026-05-12 | $2.62M derived: sum of 3 quarters · filed 2026-05-12 | $3.60M derived: sum of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | $883.40K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $1.67M derived: sum of 2 quarters · filed 2026-03-24 | $2.65M derived: sum of 3 quarters · filed 2026-03-24 | $2.83M 10-K · filed 2026-03-24 | $5.70M 10-K · filed 2025-03-25 | |||
| 2024-09-30 | $783.84K 10-Q · filed 2025-11-12 | $1.36M 10-Q · filed 2024-11-12 | $1.77M derived: sum of 2 quarters · filed 2025-11-12 | $1.95M 10-Q · filed 2025-11-12 | $3.29M 10-Q · filed 2024-11-12 | $3.37M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $985.65K 10-Q · filed 2025-08-13 | $1.93M 10-Q · filed 2025-08-13 | $2.58M derived: sum of 3 quarters · filed 2025-08-13 | $3.57M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $946.30K 10-Q · filed 2025-05-14 | $1.60M derived: sum of 2 quarters · filed 2025-05-14 | $2.58M derived: sum of 3 quarters · filed 2025-05-14 | $3.76M derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $651.52K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | $1.64M derived: sum of 2 quarters · filed 2025-03-25 | $2.82M derived: sum of 3 quarters · filed 2025-03-25 | $4.13M 10-K · filed 2025-03-25 | ||||
| 2023-09-30 | $986.45K 10-Q · filed 2024-11-12 | $2.16M derived: sum of 2 quarters · filed 2024-11-12 | $3.48M 10-Q · filed 2024-11-12 | $4.51M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $1.18M 10-Q · filed 2024-08-12 | $2.49M 10-Q · filed 2024-08-12 | $3.53M derived: sum of 3 quarters · filed 2024-08-12 | $4.59M derived: sum of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | $1.32M 10-Q · filed 2024-05-13 | $2.35M derived: sum of 2 quarters · filed 2024-05-13 | $3.41M derived: sum of 3 quarters · filed 2024-05-13 | $4.48M derived: sum of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $2.10M derived: sum of 2 quarters · filed 2024-03-25 | $3.16M derived: sum of 3 quarters · filed 2024-03-25 | $3.37M 10-K · filed 2024-03-25 | ||||
| 2022-09-30 | $1.06M 10-Q · filed 2023-11-13 | $2.13M derived: sum of 2 quarters · filed 2023-11-13 | $2.33M 10-Q · filed 2023-11-13 | $2.63M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $1.07M 10-Q · filed 2023-08-14 | $1.27M 10-Q · filed 2023-08-14 | $1.57M derived: sum of 3 quarters · filed 2023-08-14 | $1.61M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $204.64K 10-Q · filed 2023-05-15 | $505.47K derived: sum of 2 quarters · filed 2023-05-15 | $541.15K derived: sum of 3 quarters · filed 2023-05-15 | $645.13K derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $300.84K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | $336.51K derived: sum of 2 quarters · filed 2023-03-20 | $440.49K derived: sum of 3 quarters · filed 2023-03-20 | $558.70K 10-K · filed 2023-03-20 | ||||
| 2021-09-30 | $35.67K 10-Q · filed 2022-11-14 | $139.66K derived: sum of 2 quarters · filed 2022-11-14 | $257.87K 10-Q · filed 2022-11-14 | $287.04K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $103.98K 10-Q · filed 2022-08-15 | $222.19K 10-Q · filed 2022-08-15 | $251.36K derived: sum of 3 quarters · filed 2022-08-15 | $262.38K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $118.21K 10-Q · filed 2022-05-16 | $147.38K derived: sum of 2 quarters · filed 2022-05-16 | $158.40K derived: sum of 3 quarters · filed 2022-05-16 | $199.92K derived: sum of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | $29.17K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $40.19K derived: sum of 2 quarters · filed 2022-03-31 | $81.71K derived: sum of 3 quarters · filed 2022-03-31 | $40.19K 10-K · filed 2022-03-31 | ||||
| 2020-09-30 | $11.02K 10-Q · filed 2021-11-12 | $52.54K derived: sum of 2 quarters · filed 2021-11-12 | $11.02K 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | $41.52K 10-Q · filed 2021-08-16 | $45.90K 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | $4.39K 10-Q · filed 2021-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| NutriBand Inc. (NTRB) | United States | $0.109B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B |